Baclofen did not modify sexually dimorphic c-Fos expression during morphine withdrawal syndrome

Synapse

Volumn 67, Issue 3, 2013, Pages 118-126

  Pedrón, Valeria T ^a   Taravini, Irene R E ^a   Induni, Andrea S ^a,b   Balerio, Graciela N ^a,b  

^a UBA CONICET ^*  (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Baclofen; Early gene expression; GABAB receptor; Mice; Opiates; Sex differences

Indexed keywords

BACLOFEN; NALOXONE; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DENTATE GYRUS; FEMALE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; IMMUNOHISTOCHEMISTRY; MALE; MORPHINE ADDICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; SEX DIFFERENCE; WITHDRAWAL SYNDROME;

ANIMALS; BACLOFEN; FEMALE; GABA-B RECEPTOR AGONISTS; HIPPOCAMPUS; MALE; MICE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; PROTO-ONCOGENE PROTEINS C-FOS; SEX FACTORS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84872617926     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21620     Document Type: Article

References (54)

1. Araki H, Uchiyama-Tsuyuki Y, Aihara H, Yamamoto T, Ohno M, Ueki S. 1989. Effects of chronic administration of haloperidol, methamphetamine or cocaine on wet-dog shakes elicited by stimulation of the rat hippocampus. Arch Int Pharmacodyn Ther 297: 217-224.
2. Beckmann AM, Matsumoto I, Wilce PA. 1995. Immediate early gene expression during morphine withdrawal. Neuropharmacology 34: 1183-1189.
3. Belozertseva I, Andreev B. 2000. The effect of GABA-positive agents on the formation of morphine dependence and on the manifestations of a withdrawal syndrome. Eksp Klin Farmakol 63: 19-23.
4. Bester H, De Felipe C, Hunt S. 2001. The NK1 receptor is essential for the full expression of noxious inhibitory controls in the mouse. J Neurosci 3: 1039-1046.
5. Bexis S, Ong J, White J. 2001. Attenuation of morphine withdrawal signs by the GABA(B) receptor agonist baclofen. Life Sci 70: 395-401.
6. Candido J, Lutfy K, Billings B, Sierra V, Duttaroy A, Inturrisi CE, Yoburn BC. 1992. Effect of adrenal and sex hormones on opioid analgesia and opioid receptor regulation. Pharmacology Biochem Behav 42: 685-692.
7. Carlezon WA Jr, Duman RS, Nestler EJ. 2005. The many faces of CREB. Trends Neurosci 28: 436-445.
8. Cicero TJ, Nock B, Meyer ER. 1996. Gender-related differences in the antinociceptive properties of morphine. J Pharmacol Exp Ther 279: 767-773.
9. Cicero TJ, Nock B, Meyer ER. 1997. Sex-related differences in morphine's antinociceptive activity: relationship to serum and brain morphine concentrations. J Pharmacol Exp Ther 282: 939-944.
10. Cicero TJ, Ennis T, Ogden J, Meyer ER. 2000. Gender differences in the reinforcing properties of morphine. Pharmacol Biochem Behav 65: 91-96.
11. Cicero TJ, Aylward SC, Meyer ER. 2003. Gender differences in the intravenous self-administration of mu opiate agonists. Pharmacol Biochem Behav 74: 541-549.
12. Craft RM, Stratmann JA, Bartok RE, Walpole TI, King SJ. 1999. Sex differences in development of morphine tolerance and dependence in the rat. Psychopharmacology 143: 1-7.
13. Chang S, Squinto S, Harlan R. 1988. Morphine activation of c-fos expression in rat brain. Biochem Biophys Res Commun 157: 698-704.
14. D'Souza DN, Harlan RE, Garcia MM. 1999. Sexual dimorphism in the response to N -methyl-aspartate receptor antagonists and morphine on behavior and c-Fos induction in the rat brain. Neuroscience 93: 1539-1547.
15. D'Souza D, Harlan R, Garcia M. 2002. Sexually dimorphic effects of morphine and MK-801: Sex steroid-dependent and-independent mechanisms. J Appl Physiol 92: 493.
16. de Medeiros MA, Carlos Reis L, Eugenio Mello L. 2005. Stress-induced c-fos expression is differentially modulated by dexamethasone, diazepam and imipramine. Neuropsychopharmacology 30: 1246-1256.
17. Delfino MA, Stefano AV, Ferrario JE, Taravini IRE, Murer MG, Gershanik OS. 2004. Behavioral sensitization to different dopamine agonists in a parkinsonian rodent model of drug-induced dyskinesias. Behav Brain Res 152: 297-306.
18. Diaz SL, Kemmling AK, Rubio MC, Balerio GN. 2001. Lack of sex-related differences in the prevention by baclofen of the morphine withdrawal syndrome in mice. Behav Pharmacol 12: 75-79.
19. Diaz SL, Kemmling AK, Balerio GN. 2003. Baclofen reestablishes striatal and cortical dopamine concentrations during naloxone-precipitated withdrawal. Neurochem Int 42: 293-298.
20. Diaz SL, Kemmling AK, Bonavita CD, Rubio MC, Balerio GN. 2004. Baclofen reestablishes μ-opioid receptor levels modified by morphine withdrawal syndrome in either sex. Synapse 54: 24-29.
21. Diaz SL, Kemmling AK, Rubio MC, Balerio GN. 2005. Morphine withdrawal syndrome: Involvement of the dopaminergic system in prepubertal male and female mice. Pharmacol Biochem Behav 82: 601-607.
22. Diaz SL, Barros VG, Antonelli MC, Rubio MC, Balerio GN. 2006. Morphine withdrawal syndrome and its prevention with baclofen: Autoradiographic study of μ-opioid receptors in prepubertal male and female mice. Synapse 60: 132-140.
23. Diaz SL, Hermida MP, Joannas LD, Olivera M, Ridolfi A, Villaamil EC, Balerio GN. 2007. Pharmacokinetic aspects of naloxone-precipitated morphine withdrawal in male and female prepubertal mice. Biopharm Drug Disposition 28: 283-289.
24. Frenois F, Cador M, Caillé S, Stinus L, Le Moine C. 2002. Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal. Eur J Neurosci 16: 1377-1389.
25. Garcia MM, Brown HE, Harlan RE. 1995. Alterations in immediate-early gene proteins in the rat forebrain induced by acute morphine injection. Brain Res 692: 23-40.
26. Georges F, Stinus L, Le Moine C. 2000. Mapping of c-fos gene expression in the brain during morphine dependence and precipitated withdrawal, and phenotypic identification of the striatal neurons involved. Eur J Neurosci 12: 4475-4486.
27. Gestreau C, Le Guen S, Besson J-M. 2000. Is there tonic activity in the endogenous opioid systems? A c-Fos study in the rat central nervous system after intravenous injection of naloxone or naloxone-methiodide. J Comp Neurol 427: 285-301.
28. Gracy K, Dankiewicz L, Koob G. 2001. Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion. Neuropsychopharmacology 24: 152-160.
29. Hamlin AS, Buller KM, Day TA, Osborne PB. 2004. Effect of naloxone-precipitated morphine withdrawal on c-fos expression in rat corticotropin-releasing hormone neurons in the paraventricular hypothalamus and extended amygdala. Neurosci Lett 362: 39-43.
30. Harlan R, Garcia M. 1998. Drugs of abuse and immediate-early genes in the forebrain. Mol Neurobiol 16: 221-267.
31. Hayard A, Guyenet P. 1998. Pre- and postsynaptic inhibitory actions of methionine-enkephalin on identified bulbospinal neurons of the rat RVL. J Neurophysiol 80: 2003-2014.
32. Hayward MD, Duman RS, Nestler EJ. 1990. Induction of the c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of rat brain. Brain Res 525: 256-266.
33. Isaacson RL, Lanthorn TH. 1981. Hippocampal involvement in the pharmacologic induction of withdrawal-like behaviors. Fed Proc 40: 1508-1512.
34. Jolas T, Aghajanian GK. 1997. Opioids suppress spontaneous and NMDA-induced inhibitory postsynaptic currents in the dorsal raphe nucleus of the rat in vitro. Brain Res 755: 229-245.
35. Kaplan GB, Leite-Morris KA, Joshi M, Shoeb MH, Carey RJ. 2003. Baclofen inhibits opiate-induced conditioned place preference and associated induction of Fos in cortical and limbic regions. Brain Res 987: 122-125.
36. Kovács KJ. 1998. Invited review c-Fos as a transcription factor: A stressful (re)view from a functional map. Neurochem Int 33: 287-297.
37. Lambert N, Wilson W. 1996. High-threshold Ca2+ currents in rat hippocampal interneurones and their selective inhibition by activation of GABA (B) receptors. J Physiol 492 (Part 1): 115-127.
38. Le Guen S, Gestreau C, Besson J. 2001. Sensitivity to naloxone of the behavioral signs of morphine withdrawal and c Fos expression in the rat CNS: A quantitative dose response analysis. J Comp Neurol 433: 272-296.
39. Leite-Morris K, Fukudome E, Kaplan G. 2002. Opiate-induced motor stimulation is regulated by [gamma]-aminobutyric acid type B receptors found in the ventral tegmental area in mice. Neurosci Lett 317: 119-122.
40. Liu J, Nickolenko J, Sharp F. 1994. Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors. Proc Natl Acad Sci USA 91: 8537.
41. Liu W-T, Li H-C, Song X-S, Huang Z-J, Song X-J. 2009. EphB receptor signaling in mouse spinal cord contributes to physical dependence on morphine. FASEB J 23: 90-98.
42. Mannelli P, Gottheil E, Peoples JF, Oropeza VC, Van Bockstaele EJ. 2004. Chronic very low dose naltrexone administration attenuates opioid withdrawal expression. Biol Psychiatry 56: 261-268.
43. Nestler EJ. 2004. Molecular mechanisms of drug addiction. Neuropharmacology 47 (Suppl 1): 24-32.
44. Paxinos G, Franklin K. 2004. The Mouse Brain in Stereotaxic Coordinates, second ed. London: Academic Press.
45. Rudick CN, Woolley CS. 2000. Estradiol induces a phasic Fos response in the hippocampal CA1 and CA3 regions of adult female rats. Hippocampus 10: 274-283.
46. Sadée W, Wang D, Bilsky EJ. 2005. Basal opioid receptor activity, neutral antagonists, and therapeutic opportunities. Life Sci 76: 1427-1437.
47. SENASA. (Resolución 617/2002). Requisitos, condiciones y procedimientos para la habilitación técnica de laboratorios que posean bioterios de producción, mantenimiento y local de experimentación.
48. Sharf R, Sarhan M, DiLeone RJ. 2008. Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell. Biol Psychiatry 3: 175-183.
49. Sheng M, Greenberg M. 1990. The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron 4: 477.
50. Stornetta RL, Norton FE, Guyenet PG. 1993. Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats. Brain Res 624: 19-28.
51. Veinante P, Stoeckel M, Lasbennes F, Freund Mercier M. 2003. c Fos and peptide immunoreactivities in the central extended amygdala of morphine dependent rats after naloxone precipitated withdrawal. Eur J Neurosci 18: 1295-1305.
52. Wan W, Wetmore L, Sorensen CM, Greenberg AH, Nance DM. 1994. Neural and biochemical mediators of endotoxin and stress-induced c-fos expression in the rat brain. Brain Res Bull 34: 7-14.
53. Yoshimura K, Yamamoto K. 1979. Neuropharmacological studies on drug dependence. Effects due to the differences in strain, sex and drug administration time on physical dependence development and characteristics of withdrawal signs in CNS-affecting drug dependent rats. Nippon Yakurigaku Zasshi 8: 805-828.
54. Zarrindast M, Mousa-Amadi E. 1999. Effects of GABAergic system on naloxone-induced jumping in morphine-dependent mice. Eur J Pharmacol 381: 129-133.